• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Solid Biosciences Inc. - Common Stock (NQ:SLDB)

    8.280 +0.260 (+3.24%)
    Streaming Delayed Price Updated: 10:40 AM EDT, Aug 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 103,378
    Open 8.210
    Bid (Size) 8.280 (200)
    Ask (Size) 8.300 (200)
    Prev. Close 8.020
    Today's Range 8.205 - 8.430
    52wk Range 3.790 - 11.45
    Shares Outstanding 19,601,539
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an... 
    Via MarketMinute
    News headline image
    Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
     
    Via Benzinga

    Performance

    YTD
    +51.9%
    +51.9%
    1 Month
    -25.2%
    -25.2%
    3 Month
    +14.5%
    +14.5%
    6 Month
    +28.8%
    +28.8%
    1 Year
    +21.4%
    +21.4%

    More News

    Read More
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Fed Trims Rates by 0.25%: A New Era of Dovish Policy and Portfolio Rebalancing
    Via MarketMinute
    Topics Bonds Credit Cards Economy
    News headline image
    Federal Reserve Poised for September Rate Cut Amidst High Market Expectations and Powell's Jackson Hole Address
    Via MarketMinute
    Topics Bonds Credit Cards Economy
    News headline image
    Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside ↗
    Via MarketBeat
    Topics Death
    News headline image
    Solid Biosciences Stock Pops On US, Canada Nod For Gene Therapy Trials: Retail Buzz Spikes ↗
    Via Stocktwits
    News headline image
    Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand ↗
    Via Benzinga
    News headline image
    Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences
    Via MarketBeat
    Topics Earnings
    News headline image
    Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗
    Via Benzinga
    News headline image
    Can Solid Biosciences Challenge Sarepta in the DMD Market?
    Via MarketBeat
    News headline image
    Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week ↗
    Via Stocktwits
    News headline image
    Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
    Via MarketBeat
    News headline image
    Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move? ↗
    Via Stocktwits
    News headline image
    Solid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy Data ↗
    Via Benzinga
    News headline image
    Stocks Quiet As S&P 500 Nears All-Time High ↗
    Via Talk Markets
    Topics Stocks Stocks / Equities
    News headline image
    Tuesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development ↗
    Via Benzinga

    Frequently Asked Questions

    Is Solid Biosciences Inc. - Common Stock publicly traded?
    Yes, Solid Biosciences Inc. - Common Stock is publicly traded.
    What exchange does Solid Biosciences Inc. - Common Stock trade on?
    Solid Biosciences Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Solid Biosciences Inc. - Common Stock?
    The ticker symbol for Solid Biosciences Inc. - Common Stock is SLDB on the Nasdaq Stock Market
    What is the current price of Solid Biosciences Inc. - Common Stock?
    The current price of Solid Biosciences Inc. - Common Stock is 8.280
    When was Solid Biosciences Inc. - Common Stock last traded?
    The last trade of Solid Biosciences Inc. - Common Stock was at 08/04/26 10:40 AM ET
    What is the market capitalization of Solid Biosciences Inc. - Common Stock?
    The market capitalization of Solid Biosciences Inc. - Common Stock is 162.30M
    How many shares of Solid Biosciences Inc. - Common Stock are outstanding?
    Solid Biosciences Inc. - Common Stock has 162M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.